No previous studies have explored how closely women follow their psychotropic drug regimens during pregnancy. This study aimed to explore patterns of and factors associated with low adherence to psychotropic medication during pregnancy.Multinational web-based study was performed in 18 countries in Europe, North America, and Australia. Uniform data collection was ensured via an electronic questionnaire. Pregnant women were eligible to participate. Adherence was measured via the 8-item Morisky Medication Adherence Scale (MMAS-8). The Beliefs about Prescribed Medicines Questionnaire (BMQ-specific), the Edinburgh Postnatal Depression Scale (EPDS), and a numeric rating scale were utilized to measure women's beliefs, depressive symptoms, and antidepressant risk perception, respectively. Participants reporting use of psychotropic medication during pregnancy (n = 160) were included in the analysis.On the basis of the MMAS-8, 78 of 160 women (48.8

作者：Angela, Lupattelli；Olav, Spigset；Ingunn, Bj?rnsdóttir；Katri, H?meen-Anttila；Ann-Charlotte, M?rdby；Alice, Panchaud；Romana Gjergja, Juraski；Gorazd, Rudolf；Marina, Odalovic；Mariola, Drozd；Michael J, Twigg；Herbert, Juch；Myla E, Moretti；Debra, Kennedy；Andre, Rieutord；Ksenia, Zagorodnikova；Anneke, Passier；Hedvig, Nordeng

来源：Depression and anxiety 2015 年 32卷 6期